Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Mumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application (ANDA) from ...

The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...

The FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.

The rise in Biocon share price came after the company announced that its wholly-owned subsidiary, Biocon Pharma, has received final approvals for Lenalidomide capsules and Dasatinib tabs from USFDA ...

Further, the per-day toll revenue for February 2025 increased 18% YoY to Rs 18.9 crore per day, compared to Rs 15.9 crore per ...

In addition, the COMPASS trial showed aspirin plus the vascular dose of rivaroxaban (2.5 mg twice daily ... these benefits extended 9 to 15 months, guideline writers gave use of approximately ...

Further, the per-day toll revenue for February 2025 increased 18% YoY to Rs 18.9 crore per day, compared to Rs 15.9 crore ... has launched Rivaroxaban tablets (USP, 2.5 mg) in the United States ...

Lenalidomide capsules, in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg and 25 mg strengths. Lenalidomide is a medication used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma, ...

Introduction The purpose of this study is to evaluate the safety and efficacy of two different antithrombotic strategies, dual antiplatelet therapy (DAPT, aspirin and ticagrelor) and direct oral ...